Because we observed a positive effect of REV‐ERBα/β knockdown or their antagonist SR8278 on the clearance of fAβ1‐42 in microglia in vitro, we suspected that REV‐ERBα‐depletion could mitigate amyloid plaque deposition in an AD mouse model. The gene discussed is NR1D1; the disease is Alzheimer disease.